Screener
Avalo Therapeutics AVTX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Avalo Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
FAQ
- What is Avalo Therapeutics's price / sales?
- Avalo Therapeutics (AVTX) reported price / sales of 176.3× in Q4 2024.
- How has Avalo Therapeutics's price / sales changed year-over-year?
- Avalo Therapeutics's price / sales increased by 4552.2% year-over-year, from 3.8× to 176.3×.
- What is the long-term trend for Avalo Therapeutics's price / sales?
- Over 4 years (2020 to 2024), Avalo Therapeutics's price / sales has grown at a 47.4% compound annual growth rate (CAGR), from 37.4× to 176.3×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Avalo Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude